Mithra Pharmaceuticals SA (MITPF)
USD 6.75
(0.0%)
USD 6.75
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 44.33 Million | 71.7 Million | 25.76 Million | 11.04 Million | 108.34 Million | 66.16 Million |
| Cost of Revenue | 24.23 Million | 33.78 Million | 29.72 Million | 16.3 Million | 9.27 Million | 5.05 Million |
| Gross Profit | 20.09 Million | 37.92 Million | -3.95 Million | -5.26 Million | 99.06 Million | 61.1 Million |
| Operating Expenses | 83.12 Million | 73.71 Million | 101.39 Million | 105.16 Million | 76.14 Million | 50.09 Million |
| Selling, General and Administrative Expenses | 26.88 Million | 5.17 Million | 4.5 Million | 9.16 Million | 11.82 Million | 9.26 Million |
| Research and Development Expenses | 69.72 Million | 68.53 Million | 96.89 Million | 95.99 Million | 64.06 Million | 40.82 Million |
| Other Expenses | - | 28.33 Million | -1136.64 | -1223.55 | -258.17 Thousand | - |
| Cost and Expenses | 120.83 Million | 107.49 Million | 131.11 Million | 121.47 Million | 85.42 Million | 55.14 Million |
| Operating Income | -71.74 Million | -35.79 Million | -105.35 Million | -110.42 Million | 22.91 Million | 11.01 Million |
| Interest Expense | 25.27 Million | 18.22 Million | 13.77 Million | - | - | 6.13 Million |
| Income Tax Expense | 12.92 Million | 49.29 Million | -10.75 Million | -25.32 Million | -7.23 Million | -12.14 Million |
| Earnings before Tax | -178.57 Million | -14.51 Million | -143.59 Million | -137.99 Million | -37.05 Million | -43.7 Million |
| Net Income | -191.54 Million | -63.8 Million | -132.84 Million | -112.67 Million | -29.81 Million | -14.13 Million |
| Earnings Per Share Basic | -3.35 | -1.30 | -3.06 | -2.75 | -0.79 | -0.39 |
| Earnings Per Share Diluted | -3.35 | -1.30 | -3.06 | -2.75 | -0.79 | -0.39 |
| Weighted Average Shares Outstanding | 57.09 Million | 49.05 Million | 43.42 Million | 40.98 Million | 37.75 Million | 36.56 Million |
| Weighted Average Shares Outstanding (Diluted) | 57.09 Million | 49.05 Million | 43.42 Million | 40.98 Million | 37.75 Million | 36.56 Million |
| Gross Margin | 0.45 | 0.53 | -0.15 | -0.48 | 0.91 | 0.92 |
| EBIT Margin | -3.15 | -0.32 | -3.63 | -8.90 | 0.27 | 0.22 |
| Profit Margin | -4.32 | -0.89 | -5.16 | -10.20 | -0.28 | -0.21 |
| EBITDA | -139.82 Million | 16.49 Million | -94.45 Million | -95.2 Million | -26.79 Million | -34.31 Million |
| Earnings Before Tax Margin | -1.62 | -0.50 | -4.09 | -9.99 | 0.21 | 0.17 |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 44.32 Million | 18.28 Million | 17.5 Million | 7.67 Million | 3.81 Million | 71.7 Million |
| Cost of Revenue | 37.7 Million | 7.46 Million | 7.14 Million | 15.9 Million | 4.57 Million | 33.78 Million |
| Gross Profit | 6.61 Million | 10.81 Million | 10.36 Million | -8.23 Million | -756.59 Thousand | 37.92 Million |
| Operating Expenses | 83.12 Million | 65.73 Million | 62.94 Million | 37.76 Million | 21.56 Million | 73.71 Million |
| Selling, General and Administrative Expenses | - | 8.81 Million | 8.43 Million | 2.44 Million | 4.55 Million | - |
| Research and Development Expenses | - | 16.99 Million | 16.27 Million | 35.32 Million | 17.56 Million | - |
| Other Expenses | - | - | - | - | - | 28.33 Million |
| Cost and Expenses | 120.83 Million | 73.19 Million | 70.09 Million | 53.67 Million | 26.14 Million | 107.49 Million |
| Operating Income | -76.51 Million | -13.67 Million | -13.09 Million | -46 Million | -21.81 Million | -35.79 Million |
| Interest Expense | 25.27 Million | 13.11 Million | - | 12.01 Million | - | 18.22 Million |
| Income Tax Expense | 12.92 Million | 6.99 Million | 6.69 Million | -1.59 Million | 523.91 Thousand | 49.29 Million |
| Earnings before Tax | -178.57 Million | -60.91 Million | -58.33 Million | -56.64 Million | -27.89 Million | -14.51 Million |
| Net Income | -191.5 Million | -67.91 Million | -65.03 Million | -55.04 Million | -27.37 Million | -63.8 Million |
| Earnings Per Share Basic | - | -1.19 | -1.14 | -0.96 | -0.48 | - |
| Earnings Per Share Diluted | - | -1.19 | -1.14 | -0.96 | -0.48 | - |
| Weighted Average Shares Outstanding | 57.09 Million | 57.09 Million | 57.09 Million | 57.09 Million | 57.09 Million | 49.05 Million |
| Weighted Average Shares Outstanding (Diluted) | 57.09 Million | 57.09 Million | 57.09 Million | 57.09 Million | 57.09 Million | 49.05 Million |
| Gross Margin | 0.15 | 0.59 | 0.59 | -1.07 | -0.20 | 0.53 |
| EBIT Margin | - | -0.56 | -0.56 | -5.12 | -4.84 | - |
| Profit Margin | -4.32 | -3.71 | -3.71 | -7.17 | -7.17 | -0.89 |
| EBITDA | - | -10.32 Million | -9.88 Million | -39.28 Million | -18.47 Million | - |
| Earnings Before Tax Margin | -1.73 | -0.75 | -0.75 | -5.99 | -5.72 | -0.50 |
PNSE
ORLCF
2509
MFSL
2795
1389